blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2573078

EP2573078 - ACRYLAMIDE COMPOUNDS AND USE THEREOF FOR INHIBITING APOPTOSIS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  08.09.2017
Database last updated on 12.06.2024
Most recent event   Tooltip10.07.2020Lapse of the patent in a contracting state
New state(s): AL
published on 12.08.2020  [2020/33]
Applicant(s)For all designated states
Chinese PLA General Hospital
No. 28 Fuxing Road
Beijing 100853 / CN
[2013/13]
Inventor(s)01 / HE, Kunlun
No. 28 Fuxing Road
Beijing 100853 / CN
02 / LI, Song
No. 27 Taiping Road
Haidian District
Beijing 100850 / CN
03 / ZHONG, Wu
No. 27 Taiping Road
Haidian District
Beijing 100850 / CN
04 / LIU, Juan
No. 27 Taiping Road
Haidian District
Beijing 100850 / CN
05 / WANG, Lili
No. 27 Taiping Road
Haidian District
Beijing 100850 / CN
06 / LI, Xin
No. 28 Fuxing Road
Beijing 100853 / CN
07 / HU, Guoliang
No. 28 Fuxing Road
Beijing 100853 / CN
08 / WANG, Jie
No. 27 Taiping Road
Haidian District
Beijing 100850 / CN
09 / LONG, Long
No. 27 Taiping Road
Haidian District
Beijing 100850 / CN
10 / XIAO, Junhai
No. 27 Taiping Road
Haidian District
Beijing 100850 / CN
11 / ZHENG, Zhibing
No. 27 Taiping Road
Haidian District
Beijing 100850 / CN
12 / LI, Wei
No. 27 Taiping Road
Haidian District
Beijing 100850 / CN
13 / LI, Ruijun
No. 28 Fuxing Road
Beijing 100853 / CN
14 / LIU, Chunlei
No. 28 Fuxing Road
Beijing 100853 / CN
15 / TANG, Jie
No. 28, Fuxing Road
Beijing 100853 / CN
 [2013/13]
Representative(s)Lavoix
Bayerstraße 83
80335 München / DE
[N/P]
Former [2016/44]Lavoix
Bayerstrasse 83
80335 München / DE
Former [2013/13]Kling, Simone
Lavoix Munich Bayerstrasse 85a
80335 München / DE
Application number, filing date10851188.214.05.2010
[2016/44]
WO2010CN00687
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011140681
Date:17.11.2011
Language:ZH
[2011/46]
Type: A1 Application with search report 
No.:EP2573078
Date:27.03.2013
Language:EN
[2013/13]
Type: B1 Patent specification 
No.:EP2573078
Date:02.11.2016
Language:EN
[2016/44]
Search report(s)International search report - published on:CN17.11.2011
(Supplementary) European search report - dispatched on:EP17.10.2013
ClassificationIPC:C07D333/04, C07D333/10, C07D409/12, C07D295/21, C07C335/12, A61K31/381, A61K31/4709, A61K31/496, A61K31/435, A61K31/5377, A61K31/17, A61P9/00, A61P43/00
[2013/13]
CPC:
A61K31/18 (EP,US); A61K31/17 (EP,US); A61K31/381 (EP,US);
A61K31/435 (EP,US); A61K31/4453 (EP,US); A61K31/4709 (EP,US);
A61K31/496 (EP,US); A61K31/5375 (EP,US); A61K31/5377 (EP,US);
A61P43/00 (EP); A61P9/00 (EP); C07C335/12 (EP,US);
C07D295/194 (EP,US); C07D295/21 (EP,US); C07D333/24 (EP,US);
C07D409/12 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2013/13]
Extension statesBANot yet paid
MENot yet paid
RSNot yet paid
TitleGerman:ACRYLAMIDVERBINDUNGEN UND IHRE VERWENDUNG ZUR HEMMUNG VON APOPTOSE[2013/13]
English:ACRYLAMIDE COMPOUNDS AND USE THEREOF FOR INHIBITING APOPTOSIS[2013/13]
French:COMPOSÉS D'ACRYLAMIDE ET LEUR UTILISATION DANS L'INHIBITION DE L'APOPTOSE[2013/13]
Entry into regional phase14.12.2012Translation filed 
14.12.2012National basic fee paid 
14.12.2012Search fee paid 
14.12.2012Designation fee(s) paid 
14.12.2012Examination fee paid 
Examination procedure14.12.2012Examination requested  [2013/13]
14.05.2014Amendment by applicant (claims and/or description)
02.07.2014Despatch of a communication from the examining division (Time limit: M06)
05.01.2015Reply to a communication from the examining division
11.05.2015Despatch of a communication from the examining division (Time limit: M06)
05.11.2015Reply to a communication from the examining division
22.12.2015Communication of intention to grant the patent
14.04.2016Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
20.05.2016Communication of intention to grant the patent
14.09.2016Fee for grant paid
14.09.2016Fee for publishing/printing paid
14.09.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  02.07.2014
Opposition(s)03.08.2017No opposition filed within time limit [2017/41]
Fees paidRenewal fee
14.12.2012Renewal fee patent year 03
10.05.2013Renewal fee patent year 04
27.03.2014Renewal fee patent year 05
12.05.2015Renewal fee patent year 06
10.05.2016Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU14.05.2010
AL02.11.2016
AT02.11.2016
BE02.11.2016
CY02.11.2016
CZ02.11.2016
DK02.11.2016
EE02.11.2016
ES02.11.2016
FI02.11.2016
HR02.11.2016
IT02.11.2016
LT02.11.2016
LV02.11.2016
MC02.11.2016
MK02.11.2016
NL02.11.2016
PL02.11.2016
RO02.11.2016
SE02.11.2016
SI02.11.2016
SK02.11.2016
SM02.11.2016
TR02.11.2016
BG02.02.2017
NO02.02.2017
GR03.02.2017
IS02.03.2017
PT02.03.2017
IE14.05.2017
LU14.05.2017
MT14.05.2017
CH31.05.2017
LI31.05.2017
[2020/33]
Former [2020/15]HU14.05.2010
AT02.11.2016
BE02.11.2016
CY02.11.2016
CZ02.11.2016
DK02.11.2016
EE02.11.2016
ES02.11.2016
FI02.11.2016
HR02.11.2016
IT02.11.2016
LT02.11.2016
LV02.11.2016
MC02.11.2016
MK02.11.2016
NL02.11.2016
PL02.11.2016
RO02.11.2016
SE02.11.2016
SI02.11.2016
SK02.11.2016
SM02.11.2016
TR02.11.2016
BG02.02.2017
NO02.02.2017
GR03.02.2017
IS02.03.2017
PT02.03.2017
IE14.05.2017
LU14.05.2017
MT14.05.2017
CH31.05.2017
LI31.05.2017
Former [2019/52]HU14.05.2010
AT02.11.2016
BE02.11.2016
CY02.11.2016
CZ02.11.2016
DK02.11.2016
EE02.11.2016
ES02.11.2016
FI02.11.2016
HR02.11.2016
IT02.11.2016
LT02.11.2016
LV02.11.2016
MC02.11.2016
MK02.11.2016
NL02.11.2016
PL02.11.2016
RO02.11.2016
SE02.11.2016
SI02.11.2016
SK02.11.2016
SM02.11.2016
BG02.02.2017
NO02.02.2017
GR03.02.2017
IS02.03.2017
PT02.03.2017
IE14.05.2017
LU14.05.2017
MT14.05.2017
CH31.05.2017
LI31.05.2017
Former [2019/46]HU14.05.2010
AT02.11.2016
BE02.11.2016
CY02.11.2016
CZ02.11.2016
DK02.11.2016
EE02.11.2016
ES02.11.2016
FI02.11.2016
HR02.11.2016
IT02.11.2016
LT02.11.2016
LV02.11.2016
MC02.11.2016
NL02.11.2016
PL02.11.2016
RO02.11.2016
SE02.11.2016
SI02.11.2016
SK02.11.2016
SM02.11.2016
BG02.02.2017
NO02.02.2017
GR03.02.2017
IS02.03.2017
PT02.03.2017
IE14.05.2017
LU14.05.2017
MT14.05.2017
CH31.05.2017
LI31.05.2017
Former [2019/31]HU14.05.2010
AT02.11.2016
BE02.11.2016
CZ02.11.2016
DK02.11.2016
EE02.11.2016
ES02.11.2016
FI02.11.2016
HR02.11.2016
IT02.11.2016
LT02.11.2016
LV02.11.2016
MC02.11.2016
NL02.11.2016
PL02.11.2016
RO02.11.2016
SE02.11.2016
SI02.11.2016
SK02.11.2016
SM02.11.2016
BG02.02.2017
NO02.02.2017
GR03.02.2017
IS02.03.2017
PT02.03.2017
IE14.05.2017
LU14.05.2017
MT14.05.2017
CH31.05.2017
LI31.05.2017
Former [2018/43]AT02.11.2016
BE02.11.2016
CZ02.11.2016
DK02.11.2016
EE02.11.2016
ES02.11.2016
FI02.11.2016
HR02.11.2016
IT02.11.2016
LT02.11.2016
LV02.11.2016
MC02.11.2016
NL02.11.2016
PL02.11.2016
RO02.11.2016
SE02.11.2016
SI02.11.2016
SK02.11.2016
SM02.11.2016
BG02.02.2017
NO02.02.2017
GR03.02.2017
IS02.03.2017
PT02.03.2017
IE14.05.2017
LU14.05.2017
MT14.05.2017
CH31.05.2017
LI31.05.2017
Former [2018/23]AT02.11.2016
BE02.11.2016
CZ02.11.2016
DK02.11.2016
EE02.11.2016
ES02.11.2016
FI02.11.2016
HR02.11.2016
IT02.11.2016
LT02.11.2016
LV02.11.2016
MC02.11.2016
NL02.11.2016
PL02.11.2016
RO02.11.2016
SE02.11.2016
SI02.11.2016
SK02.11.2016
SM02.11.2016
BG02.02.2017
NO02.02.2017
GR03.02.2017
IS02.03.2017
PT02.03.2017
IE14.05.2017
LU14.05.2017
CH31.05.2017
LI31.05.2017
Former [2018/17]AT02.11.2016
BE02.11.2016
CZ02.11.2016
DK02.11.2016
EE02.11.2016
ES02.11.2016
FI02.11.2016
HR02.11.2016
IT02.11.2016
LT02.11.2016
LV02.11.2016
MC02.11.2016
NL02.11.2016
PL02.11.2016
RO02.11.2016
SE02.11.2016
SI02.11.2016
SK02.11.2016
SM02.11.2016
BG02.02.2017
NO02.02.2017
GR03.02.2017
IS02.03.2017
PT02.03.2017
LU14.05.2017
CH31.05.2017
LI31.05.2017
Former [2018/13]AT02.11.2016
BE02.11.2016
CZ02.11.2016
DK02.11.2016
EE02.11.2016
ES02.11.2016
FI02.11.2016
HR02.11.2016
IT02.11.2016
LT02.11.2016
LV02.11.2016
MC02.11.2016
NL02.11.2016
PL02.11.2016
RO02.11.2016
SE02.11.2016
SI02.11.2016
SK02.11.2016
SM02.11.2016
BG02.02.2017
NO02.02.2017
GR03.02.2017
IS02.03.2017
PT02.03.2017
CH31.05.2017
LI31.05.2017
LU31.05.2017
Former [2018/06]AT02.11.2016
BE02.11.2016
CZ02.11.2016
DK02.11.2016
EE02.11.2016
ES02.11.2016
FI02.11.2016
HR02.11.2016
IT02.11.2016
LT02.11.2016
LV02.11.2016
MC02.11.2016
NL02.11.2016
PL02.11.2016
RO02.11.2016
SE02.11.2016
SI02.11.2016
SK02.11.2016
SM02.11.2016
BG02.02.2017
NO02.02.2017
GR03.02.2017
IS02.03.2017
PT02.03.2017
LU31.05.2017
Former [2017/52]AT02.11.2016
BE02.11.2016
CZ02.11.2016
DK02.11.2016
EE02.11.2016
ES02.11.2016
FI02.11.2016
HR02.11.2016
IT02.11.2016
LT02.11.2016
LV02.11.2016
NL02.11.2016
PL02.11.2016
RO02.11.2016
SE02.11.2016
SI02.11.2016
SK02.11.2016
SM02.11.2016
BG02.02.2017
NO02.02.2017
GR03.02.2017
IS02.03.2017
PT02.03.2017
LU31.05.2017
Former [2017/38]AT02.11.2016
BE02.11.2016
CZ02.11.2016
DK02.11.2016
EE02.11.2016
ES02.11.2016
FI02.11.2016
HR02.11.2016
IT02.11.2016
LT02.11.2016
LV02.11.2016
NL02.11.2016
PL02.11.2016
RO02.11.2016
SE02.11.2016
SK02.11.2016
SM02.11.2016
BG02.02.2017
NO02.02.2017
GR03.02.2017
IS02.03.2017
PT02.03.2017
LU31.05.2017
Former [2017/37]AT02.11.2016
BE02.11.2016
CZ02.11.2016
DK02.11.2016
EE02.11.2016
ES02.11.2016
FI02.11.2016
HR02.11.2016
IT02.11.2016
LT02.11.2016
LV02.11.2016
NL02.11.2016
PL02.11.2016
RO02.11.2016
SE02.11.2016
SK02.11.2016
SM02.11.2016
NO02.02.2017
GR03.02.2017
IS02.03.2017
PT02.03.2017
LU31.05.2017
Former [2017/36]AT02.11.2016
BE02.11.2016
CZ02.11.2016
DK02.11.2016
EE02.11.2016
ES02.11.2016
FI02.11.2016
HR02.11.2016
LT02.11.2016
LV02.11.2016
NL02.11.2016
PL02.11.2016
RO02.11.2016
SE02.11.2016
SK02.11.2016
NO02.02.2017
GR03.02.2017
IS02.03.2017
PT02.03.2017
LU31.05.2017
Former [2017/35]AT02.11.2016
CZ02.11.2016
DK02.11.2016
EE02.11.2016
ES02.11.2016
FI02.11.2016
HR02.11.2016
LT02.11.2016
LV02.11.2016
NL02.11.2016
PL02.11.2016
RO02.11.2016
SE02.11.2016
NO02.02.2017
GR03.02.2017
IS02.03.2017
PT02.03.2017
Former [2017/34]AT02.11.2016
CZ02.11.2016
DK02.11.2016
ES02.11.2016
FI02.11.2016
HR02.11.2016
LT02.11.2016
LV02.11.2016
NL02.11.2016
PL02.11.2016
SE02.11.2016
NO02.02.2017
GR03.02.2017
IS02.03.2017
PT02.03.2017
Former [2017/33]AT02.11.2016
DK02.11.2016
ES02.11.2016
FI02.11.2016
HR02.11.2016
LT02.11.2016
LV02.11.2016
NL02.11.2016
PL02.11.2016
SE02.11.2016
NO02.02.2017
GR03.02.2017
IS02.03.2017
PT02.03.2017
Former [2017/26]AT02.11.2016
ES02.11.2016
FI02.11.2016
HR02.11.2016
LT02.11.2016
LV02.11.2016
NL02.11.2016
PL02.11.2016
SE02.11.2016
NO02.02.2017
GR03.02.2017
IS02.03.2017
PT02.03.2017
Former [2017/12]LV02.11.2016
Documents cited:Search[I]WO2010011898  (INDIANA UNIVERSITY RES TECHNOL [US], et al) [I] 1-9 * claims 11, 16, 21 * * page 2, line 24 * * the whole document *
 [XAI]  - LONG K ET AL, "Structure-activity relationship studies of salubrinal lead to its active biotinylated derivative", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, vol. 15, no. 17, ISSN 0960-894X, (20050901), pages 3849 - 3852, (20050901), XP027801504 [X] 1,2,6,8 * compound 4q * * the whole document * [A] 4 [I] 3,5,7,9
International search[A]WO2007101710  (CENIX BIOSCIENCE GMBH [DE], et al);
 [A]WO0222581  (GLIATECH INC [US], et al)
 [X]  - KAI LONG ET AL., "Structure - activity relationship studies of salubrinal lead to its active biotinylated derivative", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, (2005), vol. 15, pages 3849 - 3852, XP027801504
by applicant   - KREIDER, A. MESSING; H. DOAN; S.U. KIM; R.P. LISAK; D.E. PLEASURE, "Enrichment of Schwann cell cultures from neonatal rat sciatic nerve by differential adhesion", BRAIN RES, (1981), vol. 2, pages 433 - 444
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.